(Total Views: 943)
Posted On: 12/28/2020 7:07:34 AM
Post# of 153888
CytoDyn ....announced today the first patient first visit metric was met for the Company’s Phase 2 clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) (From the company's PR.)
Not to change the subject but did the company actually enroll an actual soul in the clinical trial?? The above sounded a little to legalese to me. I'm looking for the next leg up. TIA.
Not to change the subject but did the company actually enroll an actual soul in the clinical trial?? The above sounded a little to legalese to me. I'm looking for the next leg up. TIA.
(2)
(0)
